SBIR/STTR Research Award
SURFACE MODIFICATION OF BIOMATERIALS FOR THROMBOSIS PREVENTION
Award amount
$500,000Program and phase
SBIR · Phase IIAward year
1992Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- Not reported
- Recipient company
- SURMODICS, INC.
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- Not reported
- Solicitation number
- Not reported
- Topic code
- Not reported
Research abstract
ALL SYNTHETIC MATERIALS THAT CONTACT BLOOD EXPERIENCE PROBLEMS WITH BLOOD COMPATIBILITY. THE RAPID ADSORPTION OF PLASMA PROTEINS AND SUBSEQUENT ADHERENCE AND ACTIVATION OF PLATELETS LEADS TO THROMBUS FORMATION. WHEN PATIENTS ARE IMPLANTED WITH VASCULAR DEVICES OR UNDERGO HEMODIALYSIS PROCEDURES, MAINTENANCE LEVELS OF ANTICOAGULANTS MUST BE GIVEN TO PREVENT LIFE-THREATENING CLOT FORMATIONS. HOWEVER, THESE DRUGS HAVE VERY DANGEROUS SIDE EFFECTS. PREPARATION OF NONTHROMBOGENIC-DEVICE POLYMERS WOULD REDUCE THE NEED FOR SUCH HIGH LEVELS OF THESE DRUGS. THIS PROJECT WILL USE PHOTOCHEMICAL COUPLING REAGENTS TO SURFACE-MODIFY BIOMEDICAL DEVICE MATERIALS FOR THROMBOSIS PREVENTION. HYDROPHILIC MATERIALS WILL BE IMMOBILIZED TO PREVENT PLASMA PROTEIN DEPOSITION, AND HEPARIN WILL BE ATTACHED TO THE ENDS OF THESE SPACERS TO GIVE THE SURFACE ANTICOAGULANT ACTIVITY. PHOTOCHEMISTRY IS CHOSEN BECAUSE THIS CHEMISTRY ALLOWS GENERIC COUPLING TO A WIDE RANGE OF MEDICAL DEVICE POLYMERS. SEVERAL PHOTOACTIVATIBLE REAGENTS WILL BE PREPARED, AND THEN THE PHOTOIMMOBILIZATION OF THESE REAGENTSTO RELEVANT MATERIALS WILL BE DEMONSTRATED. IN VITRO ANTICOAGULANT AND PLATELET ADHERENCE AND ACTIVATION ASSAYS WILL BE CONDUCTED TO EVALUATE THE EFFICACIES OF THE MODIFIED SURFACES. THESE IN VITRO ANALYSES WILL LEAD TO ADDITIONAL CHEMISTRY OPTIMIZATION AND EX VIVO SHUNT TESTING OF THROMBOGENICITY AND HEMOCOMPATIBILITY IN PHASE II.
Technology keywords
Not reported